Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2023-12-19 Ownership | 2024-02-20 4:51 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner | 8,571 | $5.25 | 115,219 (Direct) | View |
| 2023-12-19 Ownership | 2024-02-20 4:51 pm | 2023-01-15 2025-01-15 | QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner | 184,857 | $0 | 115,219 (Direct) | View |
| 2023-01-15 Ownership | 2024-02-20 4:51 pm | 2023-01-15 2025-01-15 | QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Capital Group LLC Checkmate Strategic Capital Holdings LLC See Explanation of Responses 10% Owner | 50,000 | $0 | 115,219 (Direct) | View |
| 2024-02-06 Conversion(A) | 2024-02-14 4:43 pm | 2021-01-27 N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director | 3,907 | $0 | 376,849 (Direct) | View |
| 2024-02-06 Conversion(A) | 2024-02-14 4:43 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director | 1,302 | $3 | 376,849 (Direct) | View |
| 2024-02-06 Conversion(A) | 2024-02-14 4:43 pm | 2021-01-27 N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel | 26,049 | $0 | 182,000 (Direct) | View |
| 2024-02-06 Conversion(A) | 2024-02-14 4:43 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel | 8,683 | $3 | 182,000 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-13 4:00 pm | 2021-01-27 N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director | 3,907 | $0 | 392,674 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-13 4:00 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director | 1,302 | $3 | 392,674 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-13 4:00 pm | 2021-01-27 N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel | 26,049 | $0 | 197,690 (Direct) | View |
| 2024-02-06 Conversion | 2024-02-13 4:00 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel | 8,683 | $3 | 197,690 (Direct) | View |
| 2022-03-03 Option Award | 2023-06-29 06:14 am | N/A 2032-03-03 | QSAM Biosciences Inc. | QSAM | King Adam Chief Financial Officer | 35,450 | $0 | 35,450 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-23 4:30 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Sax Adriann Director | 10,455 | $0 | 35,455 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-23 4:30 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Link Jr. Charles J Director | 10,455 | $0 | 108,839 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-23 4:30 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO/Director | 72,276 | $0 | 392,056 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-23 4:30 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman | 72,276 | $0 | 393,487 (Direct) | View |
| 2023-06-23 Option Award | 2023-06-23 4:30 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. EVP Corp Dev & General Counsel | 46,365 | $0 | 193,564 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 5:13 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO / Director | 50,926 | $0 | 303,271 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 5:11 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel | 37,037 | $0 | 126,952 (Direct) | View |
| 2022-12-31 Option Award | 2023-01-04 5:08 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman | 53,241 | $0 | 305,586 (Direct) | View |
| 2022-02-21 Option Award | 2022-03-08 4:13 pm | 2022-12-31 2032-02-21 | QSAM Biosciences Inc. | QSAM | Link Jr. Charles J Director | 1,000,000 | $0 | 1,000,000 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:04 pm | N/A 2032-03-03 | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 8:02 pm | N/A 2032-03-03 | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 7:57 pm | N/A 2032-03-03 | QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman | 500,000 | $0 | 500,000 (Direct) | View |
| 2022-03-03 Option Award | 2022-03-07 7:55 pm | N/A 2032-03-03 | QSAM Biosciences Inc. | QSAM | Sax Adriann Director | 750,000 | $0 | 750,000 (Direct) | View |
| 2022-01-25 Option Award | 2022-02-17 5:22 pm | N/A 2032-01-25 | QSAM Biosciences Inc. | QSAM | Sax Adriann Director | 250,000 | $0 | 250,000 (Direct) | View |
| 2021-12-06 Ownership | 2022-02-15 1:54 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman | 10,096,775 | $0 | 20,315,575 (Direct) | View |
| 2021-08-24 Ownership | 2022-02-15 1:54 pm | N/A 2031-08-23 | QSAM Biosciences Inc. | QSAM | Piazza C Richard Executive Chairman | 127,975 | $0 | 20,315,575 (Direct) | View |
| 2021-12-06 Ownership | 2022-02-15 06:14 am | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director | 10,096,775 | $0 | 20,323,575 (Direct) | View |
| 2020-12-30 Ownership | 2022-02-15 06:14 am | N/A N/A | QSAM Biosciences Inc. | QSAM | Baum Douglas R CEO & Director | 135,975 | $0 | 20,323,575 (Direct) | View |
| 2021-12-06 Ownership | 2022-02-15 06:11 am | N/A N/A | QSAM Biosciences Inc. | QSAM | Link David Charles Director | 2,884,793 | $0 | 5,823,736 (Direct) | View |
| 2021-08-24 Ownership | 2022-02-15 06:11 am | N/A 2031-08-23 | QSAM Biosciences Inc. | QSAM | Link David Charles Director | 55,850 | $0 | 5,823,736 (Direct) | View |
| 2021-12-06 Ownership | 2022-02-14 9:58 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel and Director Director | 2,884,793 | $0 | 6,307,345 (Direct) | View |
| 2021-08-24 Ownership | 2022-02-14 9:58 pm | N/A 2031-08-23 | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel and Director Director | 539,459 | $0 | 6,307,345 (Direct) | View |
| 2021-08-24 Ownership | 2022-02-14 9:57 pm | N/A 2031-08-23 | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 454,000 | $0 | 960,456 (Direct) | View |
Ownership | 2022-02-14 9:57 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 0 | $0 | 960,456 (Direct) | View |
| 2020-12-17 Ownership | 2021-02-16 4:01 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director | 96,782 | $0.22 | 889,958 (Direct) | View |
| 2020-09-30 Ownership | 2021-02-16 4:01 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director | 705,176 | $0.22 | 889,958 (Direct) | View |
| 2020-01-06 Ownership | 2021-02-16 4:01 pm | 2020-01-06 2030-01-06 | QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director | 40,000 | $0 | 889,958 (Direct) | View |
Ownership | 2021-02-16 4:01 pm | 2018-12-01 2028-12-01 | QSAM Biosciences Inc. | QSAM | WHITNEY SCOTT W. Former Director Director | 0 | $0 | 889,958 (Direct) | View |
| 2020-12-17 Ownership | 2021-02-16 4:01 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director | 36,364 | $0.22 | 108,364 (Direct) | View |
| 2020-01-06 Ownership | 2021-02-16 4:01 pm | 2020-01-06 2030-01-06 | QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director | 40,000 | $0 | 108,364 (Direct) | View |
Ownership | 2021-02-16 4:01 pm | 2018-12-01 2028-06-01 | QSAM Biosciences Inc. | QSAM | Peitz Tristan Former Director Director | 0 | $0 | 108,364 (Direct) | View |
| 2020-12-17 Ownership | 2021-02-16 4:01 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO | 695,854 | $0.22 | 1,297,490 (Direct) | View |
| 2020-09-30 Ownership | 2021-02-16 4:01 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO | 113,636 | $0.22 | 1,297,490 (Direct) | View |
Ownership | 2021-02-16 4:01 pm | 2016-02-25 2026-02-25 | QSAM Biosciences Inc. | QSAM | Bolin Kevin Former Chairman & CEO | 0 | $0 | 1,297,490 (Direct) | View |
| 2020-10-26 Ownership | 2021-02-16 4:00 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director | 423,609 | $0.22 | 1,557,441 (Direct) | View |
| 2020-12-30 Ownership | 2021-02-16 4:00 pm | 2020-12-30 N/A | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director | 850 | $0 | 1,557,441 (Direct) | View |
Ownership | 2021-02-16 4:00 pm | 2015-11-18 2025-11-18 | QSAM Biosciences Inc. | QSAM | Nelson Christopher M. General Counsel Director | 0 | $0 | 1,557,441 (Direct) | View |
| 2020-12-17 Ownership | 2021-02-16 4:00 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 96,782 | $0.22 | 546,216 (Direct) | View |
| 2020-09-30 Ownership | 2021-02-16 4:00 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 331,834 | $0.22 | 546,216 (Direct) | View |
| 2020-01-06 Ownership | 2021-02-16 4:00 pm | 2020-01-06 2030-01-06 | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 40,000 | $0 | 546,216 (Direct) | View |
Ownership | 2021-02-16 4:00 pm | 2018-12-01 2028-12-01 | QSAM Biosciences Inc. | QSAM | Mayersohn Joel David Director | 0 | $0 | 546,216 (Direct) | View |
Ownership | 2021-01-27 9:29 pm | N/A N/A | QSAM Biosciences Inc. | QSAM | Checkmate Strategic Capital 2 LLC Paschall Charles Thomas Checkmate Strategic Capital Holdings LLC Checkmate Capital Group LLC See Explanation of Responses 10% Owner | 0 | $0 | 18,369,617 (Indirect) | View |